Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease | Synapse

November 23, 2010Circulation166 citationsOpen Access

View Full Paper

Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease

ZMZiad MallatGeneral Cardiology GLGérard LambeauCentre National de la Recherche Scientifique

Alain TedguiVascular Medicine

Key Points

Key points are not available for this paper at this time.

Abstract

International audience

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Mallat et al. (Tue,) studied this question.

synapsesocial.com/papers/6a20df0b34bef10fdaeb16fc https://doi.org/https://doi.org/10.1161/circulationaha.110.936393

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1iPLA2β: front and center in human monocyte chemotaxis to MCP-12008 · 79 citations
2Prognostic Utility of Secretory Phospholipase A2 in Patients with Stable Coronary Artery Disease2011 · 13 citations
3Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma2009 · 162 citations
4Association Between Lipoprotein-Associated Phospholipase A2 and Cardiovascular Disease: A Systematic Review2007 · 183 citations
5Role of Lipoprotein-Associated Phospholipase A <sub>2</sub> in Atherosclerosis2005 · 478 citations